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ABSTRACT
A genetic vaccine consisting of the bovine herpesvirus-1.2a (BHV-1.2a) glycoprotein D (gD) gene under the control
of the cytomegalovirus immediate-early promoter/enhancer was generated and administered to sheep
intramuscularly in the neck. All animals developed serum antibodies which recognized the homologous antigen
(BHV-1.2a strain BH-83) and also exhibited cross-reactivity against the heterologous antigen (BHV-5 strain
EVI-190). Three intramuscularly injections were given but serological responses were not improved after the
second inoculation. Specific antibodies were detected against BHV-1.2a until at least 12 months after the first
inoculation. However, the capacity to induce antibodies against BHV-5 was lower and of shorter duration than to
BHV-1.2a.
Keywords: bovine herpesvirus-1.2a, glycoprotein D gene, DNA vaccine, ELISA
RESUMO
Uma vacina geneticamente preparada com o gene da glicoproteína D do herpesvirus bovino-1.2a (BHV-1.2a)
controlado com o promotor/potenciador imediatamente precoce de citomegalovírus foi administrada no pescoço de
ovinos. Todos os animais produziram anticorpos séricos que reconheceram, em ELISA, o antígeno homólogo
(BHV-1.2a, amostra BH-83) e também mostraram reatividade cruzada contra um antígeno heterólogo (BHV-5
amostra EVI-190). Foram aplicadas três inoculações, mas não houve melhora de resposta com a terceira
inoculação. Resposta específica contra BHV-1.2a foi detectada pelo menos até 12 meses após a primeira
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inoculação, entretanto, a resposta sorológica contra o BHV-5 foi de menor intensidade e duração do que aquela
contra o BHV-1.2a.
Palavras-chave: herpesvírus bovino-1.2a, gene da glicoproteína D, vacina de DNA, ELISA
 
 
INTRODUCTION
Bovine herpesvirus 1 (BHV-1) is an important pathogen of cattle and signs and clinical manifestation are dependent
on virus strain-specific virulence. To reduce economical losses, vaccination with attenuated live or inactivated
vaccines is widely performed. However, live attenuated vaccines may cause immunesuppressions or abortions if
not attenuated sufficiently. Killed vaccines are often unable to generate protective levels of immunity for reasons of
antigen load or loss of important epitopes during inactivation (Gibbs, Rweyemamu, 1977; Monaco, 1992; den Hurk
et al., 1993b). Therefore, it is clear the need of better vaccines and in the last decade naked DNA encoding
immunogenic proteins has been introduced for vaccination (Wolff et al., 1990). So far, it has been demonstrated
that the BHV-1 glycoproteins gB, gC and gD induce protective immunity in a cattle model, therefore, one can
believe that anyone of these glycoproteins is able to induce immune response when delivered and expressed from
plasmid DNA (den Hurk et al., 1990). gD is the prime DNA vaccine candidate, indeed, it has been shown that gD
subunit vaccine is able to induce the greatest levels of neutralizing antibody and abrogate virus shedding (Babiuk
et al., 1987; den Hurk et al., 1993a). The efficacy of DNA vaccination has mainly been tested in experimental
model system and in cattle has been shown to decrease respiratory symptoms induced by BHV-1 and also it has
been shown to elicit immune responses (Cox et al., 1993; den Hurk et al., 1998). Inoculation of plasmid DNA
expression vectors has been protected chickens against avian influenza (Fynan et al., 1993; Robinson et al., 1993)
and Newcastle disease (Sakaguchi et al., 1996).
The isolation of BHV-1 from sheep (Lehmkuhl, Cutlip; 1985; Shankar, Yadav, 1987; Clark et al., 1993) and the
detection anti BHV-1 antibodies in sheep has been demonstrated (Hasler, Engels, 1986; Goyal et al., 1988; Jetteur
et al., 1990; Mayga, Sarr, 1992; Suresh, Suribabu, 1993). Therefore, the sheep is a valid model for experimental
research with BHV-1 and this model would be of great benefit for assessing its applicability to BHV-1 vaccination.
This paper describes two peroxidase labeled ELISAs using BHV-1.2a and BHV-5 antigens and compares them for its
efficacy in detecting serum antibodies in sheep injected with BHV-1.2a genes expressed from cytomegalovirus
promoter in the plasmid pCI DNA (Promega Corporation, Madison, WI, USA).
 
MATERIAL AND METHODS
The BH-83 strain of BHV1-2a and EVI-190 strain of BHV-5 were produced and titrated in Madin-Darby bovine
kidney cells grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal bovine serum
(FBS). The viruses were clarified from the culture medium by centrifugation at 1,000xg for 15min, and pelleted at
40,000xg for 90min. The pellets were ressuspended in TEN buffer (10mM Tris-Cl, 1mM EDTA, 100mM NaCl, pH
8.0) and centrifuged at 95,000xg through 8.5% to 25% ficoll 400 step gradient for 60min at 4ºC. The virus band at
the 8.5-25% ficoll interface was removed, ressuspended in TEN buffer, mixed well and pelleted at 90,000xg for
60min. BH-83 DNA was prepared from the pelleted virus by using sodium dodecyl sulphate and proteinase K lyses,
phenol-chloroform extraction and ethanol precipitation.
The 1.3 Kb Mae I fragment (Roche Diagnostics GmbH, Mannheim, Germany) containing the gD coding sequences
was filled in with the Klenow fragment of DNA polymerase and inserted into the Sma I site of plasmid pCI
mammalian expression vector
1
. The resulting plasmid with the insert oriented such that gD was in frame and
downstream of the CMV I E promoter was designed pCIgD. In frame cloning and fragment orientation were verified
by asymmetric restriction site mapping and DNA sequencing of plasmid-insert junctions. Recombinant and control
plasmid were introduced into E. coli BL21 and purified by large-scale alkaline lyses method (Birnboim, 1983).
Two groups (A and B) of six lambs of either sex aged four to six months were used and injected intramuscularly in
the neck. All animals were reinjected 8 and 16 weeks later. Vaccine formulations were prepared in a volume of
1.0ml/animal with phosphate-buffered saline (PBS: 0.1M NaH
2
PO
4
/Na
2
HPO
4
, 0.15M NaCl, pH 7.8) as diluent.
Group A was given doses of 500mg of pCIgD plasmid and group B was given also doses of 500mg of pCI plasmid
with no insert. Blood samples were collected at 0 day and days 30, 60, 90, 120, 180 and 360 after the first
inoculation.
Serum antibodies for BHV-1.2a (BH-83) and BHV-5 (EVI-190) were determined by ELISA. The antigen for ELISA
was obtained ressuspending the virus pellet (BH-83 or EVI-190) in PBS containing 2µM phenylmethylsulphonyl
fluoride and sonicated on ice at 20KHz for three cycles of 10sec. This sonicated antigen was centrifuged at 500xg
for 10min and the supernatant stored in liquid nitrogen until used as antigen. Control antigen was prepared
following the same procedure, using uninfected MBDK cells. Checkerboard titration showed that the antigen
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concentration of 15.5µg/ml was the lowest concentration, which demonstrated a positive reaction anti BHV-1 sheep
sera. The optimum serum dilution (1:50) was determined based on the lowest dilution of the positive sera tested
with negative control antigen, which showed OD values less or equal those presented by negative sera. Polystyrene
microtiter plates (Nunc-Immuno Plates PolySorp, VWR Scientific, San Diego, CA, USA) were passively adsorbed
with 50µl of ELISA antigen per well diluted in 0.1M carbonate-bicarbonate buffer and incubated overnight at 4ºC.
Afterwards, plates were blocked with PBS 0.05% - Tween 20 - 0.5% Casein. Dilutions of sheep sera were prepared
in PBS-Tween-Casein and dispensed in 50µl/well. Plates were washed six times with PBS0.05% - Tween 20 and
incubated with 1:8000 dilution of mouse anti-sheep IgG peroxidase conjugate for 1 hour at 37ºC. After extensive
washing, o-phenylene-diamine dihydrochloride (OPD) and H
2
O
2
 were added as substrate and absorbance was
measured at 492 nm. The ELISA data was analyzed with the aid of a statistical software (Systat 7.0, SPSS Inc.,
Chicago, IL) and the data was transformed prior to performing the analysis by log transformation and considered
for statistical significance the level of 5%.
 
RESULTS
Transformation of E. coli BL21 with recombinant plasmid resulted in generation of pCIgD DNA vaccine. To test the
potency of this vaccine one group of six sheep were injected three times with 500 mg of pCIgD and another group
of six animals, used as control, also were injected three times with 500 mg of parental pCI vector without the
inserted gene. A comparison between the OD means from animals injected with pCIgD and negative controls
injected with pCI was used to determine ELISA cut-off that was significantly different (P< 0.05). All sera of both
groups were negative at the time of first injection. Analysis of sera by ELISA BHV-1.2a and ELISA BHV-5 showed
that injection with pCIgD was able to induce specific response and that the response against BHV-1.2a was
significantly higher than BHV-5 (P< 0.05). The antibody response decreased somewhat over time, but when the
animals received the second injection still had higher response (P< 0.05) than the control group. As illustrated in
Fig.1, the second injection (day 60) leaded to a strong response and the level of antibodies against BHV-5 was
lower. One hundred and twenty days after the first injection the animals were inoculated again and at day 150
another decrease in serum antibodies was observed. At that time the antibody levels were also significantly higher
in the pCIgD-vaccinated group that compared with the control group. By days 180 and 210, the serum antibody
levels decreased and remained in decline (P< 0.05) from day 210 to 360. At day 360 all six animals were still
positive in ELISA BHV-1.2a but the level of antibodies was not detected in ELISA BHV-5. None of the six sheep
injected with parental pCI vector exhibited any ELISA detected antibody to BHV-1.2a/BHV-5 throughout the
duration of experiment.
 
DISCUSSION
It was demonstrated the ability of an injected plasmid, containing the gD gene from BH-83 strain, a BHV-1.2a
isolate, to cause specific seroconversion in sheep. By using two ELISAs system it was shown that sera reacted with
these two related antigens but response to BH-83, homologous virus strain, was consistently higher than those to
EVI-190, a BHV-5 strain. The examination of DNA sequences of both viruses indicated that the two open reading
frames of gD extends 1254 base pairs, potentially encoding a protein with a molecular mass of about 417
kilodaltons, including the signal sequence. Therefore, the derived protein sequence of BH-83 is similar to that of
open reading frames found in the analogous head-to-head orientation with respect to gD of EVI-190. Comparison
of gD sequences of these two isolates revealed 83% homology. Alignment of deduced sequences of polypeptides of
BH-83 and EVI-190 exhibited characteristics typical for glycoproteins and exhibited 63% identity. It can be seen in
the alignment the two sequences that the greatest homology is located in domains with structural importance such
as anchor sequences, N-glycosilation sites and putative signal. Probably because these differences found the
antibody levels detected against BH-83 were consistently higher than those to EVI-190.
The presence of ELISA detected antibodies in the pCIgD injected sheep suggests that the expressed protein
retained their native antigenic properties. The antigen used in all testes (BHV-1.2a and BHV-5 ELISAs) was
obtained from MDBK virus produced rather then from recombinant gD-infected cells lysates and it proved the
suitability of such antigen for detection of BHV-1/BHV-5 gD specific antibodies. In this report, it was observed a
significant increase in average absorbance values after the second injection booster (P< 0.05). A slight decrease in
the serological response was observed after the second booster showing that a good serological response can be
obtained after just a single or double injection. Then it was demonstrated that IM injection of plasmid encoding gD
induces a good antibody production in sheep but the magnitude of the response was not improved by multiples
injection. Others have found that animals, which received high dose of recombinant plasmid produced high ELISA
titers (Cox et al., 1993). Because of these studies, the same dose of plasmid was delivered per animal. In the
present trial, it was selected the neck of the animal because of accessibility and also because in that region one can
found the same draining lymphonodes that respond to BHV-1 in case of natural infection. In other studies, partial
protection could be achieved with as little as 1-10µg of plasmid DNA per dose, and that increasing the dose to 50m
g per injection resulted in seroconversion of 100% of the pigs (Gerds et al., 1997). Chickens were injected with
100µg of NDV F protein (Sakaguchi et al., 1996) or 100-200µg of influenza HA construct (Fynan et al., 1993;
Robinson et al., 1993), and mice 50µg of pp89 plasmid (Gonzalez et al., 1996) or 100-200mg of LCMV
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nucleoprotein expression vector (Pedroza-Martins et al., 1995; Yokoyama et al., 1995) have been protected from a
lethal challenge.
From the results obtained in the present work it was clear that there are some cross reactivity between the
serological response against gD of BHV-1.2a and BHV-5. The ELISA reactivity against BHV-5 was always at levels
below those attained for BHV-1.2a. Nowadays we are constructing plasmids for gB, gC, gD and gG of both viruses
and by mixing these different plasmids it is possible to extend the cross reactivity of the immune response. DNA
immunization is though to induce both humoral and cellular immunity, because this kind of immunization is able to
provide access of endogenously produced antigens to the MHC I and II-restricted pathways (Raz et al., 1994;
Justewicz et al., 1995; Ciernik et al., 1996). In murine models the antibody isotype induced by DNA immunization
is predominantly IgG2a with a 10 to 100-fold excess over IgG1 (Coutelier et al., 1987). Compared to IgG1, IgG2a
has the advantage that it can activate both the classical and the alternative pathways of complement fixation
(Klaus et al., 1979). IgG2a is probably produced after intramuscular immunization, probably because the muscle
cells are captured by antigen presenting cells, and how the antigen presentation changed, it is sufficient to alter
the type of immune response. Some studies have reported natural occurrence of antibodies against BHV-1 and
BHV-5 in sheep (Lindner et al., 1993; Hage et al., 1997) and, in view of that it is probably that sheep is also a
natural host for both viruses, and is a valid model for the proposed study. The present work shows that the DNA
vaccination has enormous potential and continuing research is needed to well characterize the cell-mediated
immune response induced in sheep as well to optimize dose, formulations and delivery of DNA vaccine with a view
to enhancing antigen-specific immune response.
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